ABRAHAM ABUCHOWSKI
Pilots at Bunnvale Rd, Califon, NJ

License number
New Jersey A2506046
Issued Date
Sep 2016
Expiration Date
Sep 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
62 Bunnvale Rd, Califon, NJ 07830

Personal information

See more information about ABRAHAM ABUCHOWSKI at radaris.com
Name
Address
Phone
Abraham Abuchowski, age 76
62 Bunnvale Rd, Califon, NJ 07830
(908) 638-5783
Abraham Abuchowski
High Bridge, NJ
(908) 638-4253
(908) 638-5783
Abraham Abuchowski, age 77
1261 Roosevelt Blvd, Vineland, NJ 08361
Abraham Abuchowski, age 77
1265 Roosevelt Blvd, Vineland, NJ 08361
(856) 692-6180
Abraham Abuchowski, age 64
1281 Roosevelt Blvd, Vineland, NJ 08361
(856) 692-5345

Professional information

Abraham Abuchowski Photo 1

Hemoglobin Compositions

US Patent:
2010031, Dec 9, 2010
Filed:
Jun 9, 2010
Appl. No.:
12/797582
Inventors:
Abraham Abuchowski - Califon NJ, US
Steven Sloshberg - Union NJ, US
Keith O'Hare - East Windsor NJ, US
Assignee:
Prolong Pharmaceuticals, LLC - South Plainfield NJ
International Classification:
A61K 38/42, A61P 7/00
US Classification:
514 135
Abstract:
The invention provides compositions containing hemoglobin, particularly PEGylated hemoglobin. The PEGylated hemoglobin molecule is capable of transferring oxygen or carbon monoxide bound thereto to a tissue with which it is in proximity. Exemplary PEGylated hemoglobin formulations of the invention are virally inactivated. Various compositions of the invention include deoxygenated hemoglobin, which may be conjugated with one or more water-soluble polymer. PEGylated hemoglobin includes those species in which the iron atom of the hemoglobin molecule is not bound to oxygen or any other species, and hemoglobin molecules in which a species other than oxygen, e.g., carbon monoxide, is bound to the iron atom. The compositions of the invention are formulated as hypo-, iso- or hypertonic solutions of the PEGylated hemoglobin. The compositions are of use to treat and/or ameliorate disease, injury and insult by providing for the oxygenation of tissues and/organs.


Abraham Abuchowski Photo 2

Modified Erythropoietin

US Patent:
2010018, Jul 22, 2010
Filed:
Jul 16, 2007
Appl. No.:
12/376333
Inventors:
Abraham Abuchowski - Califon NJ, US
Lihsyng Stanford Lee - Cranbury NJ, US
Assignee:
PROLONG PHARMACEUTICALS, INC. - Monmouth Junction NJ
International Classification:
A61K 38/18, C07K 14/505, A61P 7/00
US Classification:
514 12, 530380
Abstract:
This invention relates to novel protein conjugates, in particular, to novel pegylated proteins, and their methods of making and use. One aspect of the present invention relates to pegylated-erythropoietin having greater clinical efficacy and stability during shipment and storage than current erythropoietin formulations.